Tamsulosin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
Pat Palmer (talk | contribs) (WPAttribution) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | ||
{{TOC|right}} | |||
==History== | ==History== | ||
Flomax brand of tamsulosin was approved by the [[Food and Drug Administration]] in the [[United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1997.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=020579 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=077451 Drugs@FDA]. U S Food and Drug Administration</ref> | Flomax brand of tamsulosin was approved by the [[Food and Drug Administration]] in the [[United States of America|United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1997.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=020579 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=077451 Drugs@FDA]. U S Food and Drug Administration</ref> | ||
==Pharmacology== | ==Pharmacology== | ||
| Line 12: | Line 12: | ||
===Toxicity=== | ===Toxicity=== | ||
== | ==Attribution== | ||
{{ | {{WPAttribution}} | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 13:23, 1 July 2024
In medicine, tamsulosin is a selective antagonist of alpha1-adrenergic receptors.
History
Flomax brand of tamsulosin was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1997.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2007.[2]
Pharmacology
Administration
Distribution
Metabolism
Excretion
Toxicity
Attribution
- Some content on this page may previously have appeared on Wikipedia.